Document is current
Any future updates will be listed below
-
Authors
Habek, Mario https://orcid.org/0000-0002-3360-1748
Adamec, Ivan
Gabelić, Tereza
Barun, Barbara
Krbot Skorić, Magdalena
-
Funding
Funding for this research was provided by:
Hrvatska Zaklada za Znanost (Installation Research project 2622)
- License Information
-
More Information
Article History
Received: 23 April 2025
Revised: 9 September 2025
Accepted: 11 September 2025
First Online: 20 September 2025
Declarations
:
: MH: received consultation and/or speaker fees from Biogen, Merck, Novartis, Roche, Astra Zeneca, and Amgen. IA: received consultation and/or speaker fees from Biogen, Merck, Novartis, Roche, and Astra Zeneca. TG: received consultation and/or speaker fees from Biogen, Merck, Novartis, Roche, and Astra Zeneca. BB: received consultation and/or speaker fees from Biogen, Merck, Novartis, Roche, and Astra Zeneca. MKS: received consultation and/or speaker fees from Sanofi Genzyme and Roche.
